R. Camsonne

431 total citations
20 papers, 361 citations indexed

About

R. Camsonne is a scholar working on Molecular Biology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, R. Camsonne has authored 20 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Pharmacology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in R. Camsonne's work include Neuroscience and Neuropharmacology Research (4 papers), Medical Imaging Techniques and Applications (3 papers) and Ion channel regulation and function (3 papers). R. Camsonne is often cited by papers focused on Neuroscience and Neuropharmacology Research (4 papers), Medical Imaging Techniques and Applications (3 papers) and Ion channel regulation and function (3 papers). R. Camsonne collaborates with scholars based in France, United Kingdom and Japan. R. Camsonne's co-authors include Louisa Barré, M. Mazière, Danièle Debruyne, C. Crouzel, D. Comar, A. Syrota, Maryline Moulin, C. Prenant, J. Sastre and Jean‐Claude Baron and has published in prestigious journals such as Journal of Chromatography A, Psychopharmacology and European Journal of Pharmacology.

In The Last Decade

R. Camsonne

19 papers receiving 340 citations

Peers

R. Camsonne

CMN

RNMI

NEURO

ONCOL

Yvonne Lewis United Kingdom

Evgeny Shchukin Sweden

Claudia Keller Switzerland

Alexander S. Bender Canada

Sac-Pham Tang United Kingdom

Denis Fournier France

James E. Liebmann United States

Miho Shukuri Japan

M. Crouzel France

Selena Milicevic Sephton United Kingdom

Yvonne Lewis United Kingdom

R. Camsonne

117 ×0.8

CMN

160 ×1.2

52 ×0.6

RNMI

67 ×1.0

NEURO

51 ×1.3

ONCOL

Citations per year, relative to R. Camsonne R. Camsonne (= 1×) peers Yvonne Lewis

Countries citing papers authored by R. Camsonne

Since Specialization

Citations

This map shows the geographic impact of R. Camsonne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Camsonne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Camsonne more than expected).

Fields of papers citing papers by R. Camsonne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Camsonne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Camsonne. The network helps show where R. Camsonne may publish in the future.

Co-authorship network of co-authors of R. Camsonne

This figure shows the co-authorship network connecting the top 25 collaborators of R. Camsonne. A scholar is included among the top collaborators of R. Camsonne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Camsonne. R. Camsonne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sobrio, Franck, Danièle Debruyne, Martine Dhilly, et al.. (2005). Evaluation in rats and primates of [11C]-mecamylamine, a potential nicotinic acetylcholine receptor radioligand for positron emission tomography. Neurochemistry International. 46(6). 479–488. 3 indexed citations

Debruyne, Danièle, et al.. (2003). Short-term pharmacokinetics and brain distribution of mecamylamine as a preliminary to carbon-11 labeling for nicotinic receptor investigation. Journal of Pharmaceutical Sciences. 92(5). 1051–1057. 36 indexed citations

Camsonne, R., D Pottier, & Pierre Bustany. (1998). [Xenografts: clinical trials and perspectives].. PubMed. 27(18). 865–8. 1 indexed citations

Camsonne, R., Louisa Barré, Marie-Christine Petit-Taboué, et al.. (1993). Positron emission tomographic studies of [11C]MDL 72222, a potential 5-HT3 receptor radioligand: Distribution, kinetics and binding in the brain of the baboon. Neuropharmacology. 32(1). 65–71. 16 indexed citations

Camsonne, R., et al.. (1993). [Therapeutic potential of Ro 5-3335. New active benzodiazepine in vitro against HIV-1 viruses resistant or non-resistant to AZT].. PubMed. 48(2). 105–7.

Barré, Louisa, Danièle Debruyne, Gilles Bonvento, et al.. (1992). Synthesis and regional rat brain distribution of [11C]MDL 72222: a 5HT3 receptor antagonist. International Journal of Radiation Applications and Instrumentation Part A Applied Radiation and Isotopes. 43(4). 509–516. 13 indexed citations

Petit-Taboué, Marie-Christine, Jean‐Claude Baron, Louisa Barré, et al.. (1991). Brain kinetics and specific binding of [11C]PK 11195 to ω3 sites in baboons: positron emission tomography study. European Journal of Pharmacology. 200(2-3). 347–351. 73 indexed citations

Camsonne, R., et al.. (1989). Quinidine disposition in relation to antipyrine elimination and debrisoquine phenotype in alcoholic patients with and without cirrhosis.. PubMed. 9(5). 319–25. 2 indexed citations

Camsonne, R.. (1987). Dopamine receptors in brain and periphery: Some prospects. Neurochemistry International. 10(1). 35–37. 3 indexed citations

10.

Camsonne, R., et al.. (1986). [Efficacy of cyclosporin in corticoid-dependent splenectomy-resistant lupus with hematologic manifestations].. PubMed. 15(2). 76–76. 3 indexed citations

11.

Camsonne, R., et al.. (1986). Carbon 11 labelling of PK11195 and visualization of benzodiazepine peripheral receptors using positron emission tomography. 17(3). 383. 3 indexed citations

12.

Camsonne, R., C. Crouzel, D. Comar, et al.. (1984). Synthesis of N‐(¹¹C) methyl, N‐(methyl‐1 propyl), (chloro‐2 phenyl)‐1 isoquinoleine carboxamide‐3 (PK 11195): A new ligand for peripheral benzodiazepine receptors. Journal of Labelled Compounds and Radiopharmaceuticals. 21(10). 985–991. 137 indexed citations

13.

Camsonne, R., et al.. (1984). A Simple Fluorescence High-Performance Liquid Chromatographic Assay for Dihydroquinidine in Serum. Therapeutic Drug Monitoring. 6(4). 471–473. 1 indexed citations

14.

Camsonne, R., et al.. (1984). Unexpected apparent first-order elimination kinetics of phenytoin in the therapeutic concentrations range.. PubMed. 4(2). 113–5. 1 indexed citations

15.

Moulin, Maryline, et al.. (1982). Serum level monitoring and therapeutic effect of haloperidol in schizophrenic patients. Psychopharmacology. 76(4). 346–350. 16 indexed citations

16.

Moulin, Maryline, et al.. (1981). Hydrophilic ion-pair reversed-phase high-performance liquid chromatography for the simultaneous assay of isoniazid and acetylisoniazid in serum: A microscale procedure. Journal of Chromatography B Biomedical Sciences and Applications. 226(1). 250–254. 17 indexed citations

17.

Debruyne, Danièle, et al.. (1981). Identification and differentiation of resinous cannabis and textile cannabis: combined use of HPLC and high-resolution GLC.. PubMed. 33(2). 49–58. 7 indexed citations

18.

Debruyne, Danièle, et al.. (1980). Wall-coated open tubular column coupled with nitrogen-selective detector for routine glc determination of diazepam, meprobamate, phenylbutazone, and thioridazine in serum. Journal of Pharmaceutical Sciences. 69(7). 835–838. 5 indexed citations

19.

Moulin, Maryline, et al.. (1979). Gas chromatography-electron-impact and chemical-ionization mass spectrometry of haloperidol and its chlorinated homologue. Journal of Chromatography A. 178(1). 324–329. 20 indexed citations

20.

Moulin, Maryline, et al.. (1978). A practical proposal for Arginine-Vasopressin radioimmunoassay. Clinica Chimica Acta. 88(2). 363–374. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact